ABOUT THIS EVENT

180 Life Sciences Corp. (Nasdaq: ATNF), a clinical-stage biotechnology company focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University, rings the Nasdaq Opening Bell remotely from across the country.

Dr. James Woody, CEO, rings the Opening Bell alongside the Company’s team in a virtual bell ringing ceremony.